These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 10079007

  • 1. Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
    Varga G, Kordás K, Burghardt B, Gacsályi I, Szénási G.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):315-23. PubMed ID: 10079007
    [Abstract] [Full Text] [Related]

  • 2. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K, Saito T, Saeki M, Ninomiya K, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1997 Oct 19; 47(10):1130-3. PubMed ID: 9368707
    [Abstract] [Full Text] [Related]

  • 3. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat.
    Brzozowski T, Konturek PC, Konturek SJ, Kwiecién S, Pajdo R, Brzozowska I, Hahn EG.
    J Clin Gastroenterol; 1998 Oct 19; 27 Suppl 1():S125-37. PubMed ID: 9872509
    [Abstract] [Full Text] [Related]

  • 4. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C, Varga G, Dobronyi I, Papp M.
    Br J Pharmacol; 1989 Mar 19; 96(3):661-9. PubMed ID: 2470456
    [Abstract] [Full Text] [Related]

  • 5. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M, Erlacher U, Schwizer W, Löchner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A.
    Gastroenterology; 1991 Aug 19; 101(2):503-11. PubMed ID: 2065926
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats.
    Wu CL, Hung CR, Chang FY, Pau KY, Wang PS.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr 19; 367(4):406-13. PubMed ID: 12690433
    [Abstract] [Full Text] [Related]

  • 7. Peripheral apelin-13 administration inhibits gastrointestinal motor functions in rats: The role of cholecystokinin through CCK1 receptor-mediated pathway.
    Bülbül M, Sinen O, Birsen İ, Izgüt-Uysal V.
    Neuropeptides; 2017 Jun 19; 63():91-97. PubMed ID: 28012561
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function.
    Tachibana I, Kanagawa K, Yamamoto Y, Otsuki M.
    J Pharmacol Exp Ther; 1996 Dec 19; 279(3):1404-12. PubMed ID: 8968365
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
    Varga G, Papp M, Scarpignato C.
    Fundam Clin Pharmacol; 1989 Dec 19; 3(3):295-306. PubMed ID: 2475419
    [Abstract] [Full Text] [Related]

  • 10. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C.
    Ann N Y Acad Sci; 1994 Mar 23; 713():219-25. PubMed ID: 8185162
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of gastric emptying and intestinal transit by amphetamine through a mechanism involving an increased secretion of CCK in male rats.
    Doong ML, Lu CC, Kau MM, Tsai SC, Chiao YC, Chen JJ, Yeh JY, Lin H, Huang SW, Chen TS, Chang FY, Wang PS.
    Br J Pharmacol; 1998 Jul 23; 124(6):1123-30. PubMed ID: 9720782
    [Abstract] [Full Text] [Related]

  • 12. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C, Kisfalvi I, D'Amato M, Varga G.
    Aliment Pharmacol Ther; 1996 Jun 23; 10(3):411-9. PubMed ID: 8791971
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of gene expression of pancreatic secretory trypsin inhibitor-61 and -56 by bile and pancreatic juice in rats.
    Miyasaka K, Funakoshi A, Nakamura E, Teraoka H.
    Pancreas; 1995 Oct 23; 11(3):246-55. PubMed ID: 8577678
    [Abstract] [Full Text] [Related]

  • 15. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats.
    Li Y, Hao Y, Zhu J, Owyang C.
    Gastroenterology; 2000 Jun 23; 118(6):1197-207. PubMed ID: 10833495
    [Abstract] [Full Text] [Related]

  • 16. Effects of juice from Morinda citrifolia (Noni) on gastric emptying in male rats.
    Pu HF, Huang WJ, Tseng WM, Wang SW, Liu YW, Doong ML, Wang PS.
    Chin J Physiol; 2004 Dec 31; 47(4):169-74. PubMed ID: 15803749
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C, Liddle RA, Williams JA, Grendell JH.
    Gut; 1987 Dec 31; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [Abstract] [Full Text] [Related]

  • 18. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K, Saito T, Wakatsuki K, Saeki M, Kato T, Kasai H, Kimura K, Fujii M.
    Arzneimittelforschung; 1998 Jan 31; 48(1):52-4. PubMed ID: 9522032
    [Abstract] [Full Text] [Related]

  • 19. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
    Shiratori K, Watanabe S, Shimizu K, Moriyoshi Y, Chang JH, Takeuchi T.
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan 31; 86(1):70-6. PubMed ID: 2471850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.